Cargando…

Serum uric acid and the incidence of CKD and hypertension

BACKGROUND: Uric acid (UA) levels correlate positively with the prevalence of chronic kidney disease (CKD) and/or hypertension. We tested the hypothesis that UA may also have a link to a new incidence of CKD and hypertension. METHODS: Study design is a cohort study and the predictor is UA levels. Of...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuriyama, Satoru, Maruyama, Yukio, Nishio, Shinichiro, Takahashi, Yasuhito, Kidoguchi, Satoshi, Kobayashi, Chisa, Takahashi, Daisuke, Sugano, Naoki, Hosoya, Tatsuo, Yokoo, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4679779/
https://www.ncbi.nlm.nih.gov/pubmed/25967597
http://dx.doi.org/10.1007/s10157-015-1120-4
_version_ 1782405581267533824
author Kuriyama, Satoru
Maruyama, Yukio
Nishio, Shinichiro
Takahashi, Yasuhito
Kidoguchi, Satoshi
Kobayashi, Chisa
Takahashi, Daisuke
Sugano, Naoki
Hosoya, Tatsuo
Yokoo, Takashi
author_facet Kuriyama, Satoru
Maruyama, Yukio
Nishio, Shinichiro
Takahashi, Yasuhito
Kidoguchi, Satoshi
Kobayashi, Chisa
Takahashi, Daisuke
Sugano, Naoki
Hosoya, Tatsuo
Yokoo, Takashi
author_sort Kuriyama, Satoru
collection PubMed
description BACKGROUND: Uric acid (UA) levels correlate positively with the prevalence of chronic kidney disease (CKD) and/or hypertension. We tested the hypothesis that UA may also have a link to a new incidence of CKD and hypertension. METHODS: Study design is a cohort study and the predictor is UA levels. Of the 15,470 screened cases, 8223 participants without CKD were eligible for the analysis of the incidence of CKD. Among these CKD candidates, 7569 participants were eligible for the analysis of the new development of hypertension. The observation period was 4 years. RESULTS: Relationship of UA with new cases of CKD. Higher UA levels had a closer association with the new development of CKD; 1.1 % (UA < 5 mg/dL), 1.5 % (5.0–5.9 mg/dL), 1.7 % (6.0–6.9 mg/dL), and 3.4 % (≧7 mg/dL), respectively (p < 0.001 by the Chi-square test). Cox proportional hazard analysis showed that the estimates of the CKD development were eGFR [Hazard Ratio (HR) 0.816, 95 % confidence intervals (CI) 0.791–0.840] and male gender (HR 0.562, 95 % CI 0.322–0.982). UA levels and new development of hypertension. Higher UA levels had a closer association with the new development of hypertension; 5.0 % (UA < 5 mg/dL), 8.9 % (5.0–5.9 mg/dL), 10.6 % (6.0–6.9 mg/dL), and 11.8 % (≧7 mg/dL), respectively (p < 0.001 by the Chi-square test). Cox proportional hazard analysis showed that the estimates of the hypertension development were BMI (HR 1.190, 95 % CI 1.155–1.226), age (HR 1.021, 95 % CI 1.010–1.032), HDL-cholesterol (HR 1.013, 95 % CI 1.007–1.019), male gender (HR 1.791, 95 % CI 1.338–2.395), UA level (HR 1.112, 95 % CI 1.024–1.207), and eGFR (HR 1008, 95 % CI 1.002–1.013). Furthermore, the logistic analysis showed that the odds ratio (OR) to estimate hypertension in the high UA group (UA ≧ 7 mg/dL; OR 1.33, 95 % CI 1.01–1.80) was greater than that in the low UA group (UA < 5 mg/dL). Kaplan–Meier analysis also confirmed the finding that the higher the UA levels the greater the hypertension development (p < 0.001 by the Log-rank test and Cox proportional hazard analysis). CONCLUSION: High UA levels are associated with the new development of hypertension, but not with the incidence of CKD.
format Online
Article
Text
id pubmed-4679779
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer Japan
record_format MEDLINE/PubMed
spelling pubmed-46797792015-12-22 Serum uric acid and the incidence of CKD and hypertension Kuriyama, Satoru Maruyama, Yukio Nishio, Shinichiro Takahashi, Yasuhito Kidoguchi, Satoshi Kobayashi, Chisa Takahashi, Daisuke Sugano, Naoki Hosoya, Tatsuo Yokoo, Takashi Clin Exp Nephrol Original Article BACKGROUND: Uric acid (UA) levels correlate positively with the prevalence of chronic kidney disease (CKD) and/or hypertension. We tested the hypothesis that UA may also have a link to a new incidence of CKD and hypertension. METHODS: Study design is a cohort study and the predictor is UA levels. Of the 15,470 screened cases, 8223 participants without CKD were eligible for the analysis of the incidence of CKD. Among these CKD candidates, 7569 participants were eligible for the analysis of the new development of hypertension. The observation period was 4 years. RESULTS: Relationship of UA with new cases of CKD. Higher UA levels had a closer association with the new development of CKD; 1.1 % (UA < 5 mg/dL), 1.5 % (5.0–5.9 mg/dL), 1.7 % (6.0–6.9 mg/dL), and 3.4 % (≧7 mg/dL), respectively (p < 0.001 by the Chi-square test). Cox proportional hazard analysis showed that the estimates of the CKD development were eGFR [Hazard Ratio (HR) 0.816, 95 % confidence intervals (CI) 0.791–0.840] and male gender (HR 0.562, 95 % CI 0.322–0.982). UA levels and new development of hypertension. Higher UA levels had a closer association with the new development of hypertension; 5.0 % (UA < 5 mg/dL), 8.9 % (5.0–5.9 mg/dL), 10.6 % (6.0–6.9 mg/dL), and 11.8 % (≧7 mg/dL), respectively (p < 0.001 by the Chi-square test). Cox proportional hazard analysis showed that the estimates of the hypertension development were BMI (HR 1.190, 95 % CI 1.155–1.226), age (HR 1.021, 95 % CI 1.010–1.032), HDL-cholesterol (HR 1.013, 95 % CI 1.007–1.019), male gender (HR 1.791, 95 % CI 1.338–2.395), UA level (HR 1.112, 95 % CI 1.024–1.207), and eGFR (HR 1008, 95 % CI 1.002–1.013). Furthermore, the logistic analysis showed that the odds ratio (OR) to estimate hypertension in the high UA group (UA ≧ 7 mg/dL; OR 1.33, 95 % CI 1.01–1.80) was greater than that in the low UA group (UA < 5 mg/dL). Kaplan–Meier analysis also confirmed the finding that the higher the UA levels the greater the hypertension development (p < 0.001 by the Log-rank test and Cox proportional hazard analysis). CONCLUSION: High UA levels are associated with the new development of hypertension, but not with the incidence of CKD. Springer Japan 2015-05-13 2015 /pmc/articles/PMC4679779/ /pubmed/25967597 http://dx.doi.org/10.1007/s10157-015-1120-4 Text en © The Author(s) 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Kuriyama, Satoru
Maruyama, Yukio
Nishio, Shinichiro
Takahashi, Yasuhito
Kidoguchi, Satoshi
Kobayashi, Chisa
Takahashi, Daisuke
Sugano, Naoki
Hosoya, Tatsuo
Yokoo, Takashi
Serum uric acid and the incidence of CKD and hypertension
title Serum uric acid and the incidence of CKD and hypertension
title_full Serum uric acid and the incidence of CKD and hypertension
title_fullStr Serum uric acid and the incidence of CKD and hypertension
title_full_unstemmed Serum uric acid and the incidence of CKD and hypertension
title_short Serum uric acid and the incidence of CKD and hypertension
title_sort serum uric acid and the incidence of ckd and hypertension
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4679779/
https://www.ncbi.nlm.nih.gov/pubmed/25967597
http://dx.doi.org/10.1007/s10157-015-1120-4
work_keys_str_mv AT kuriyamasatoru serumuricacidandtheincidenceofckdandhypertension
AT maruyamayukio serumuricacidandtheincidenceofckdandhypertension
AT nishioshinichiro serumuricacidandtheincidenceofckdandhypertension
AT takahashiyasuhito serumuricacidandtheincidenceofckdandhypertension
AT kidoguchisatoshi serumuricacidandtheincidenceofckdandhypertension
AT kobayashichisa serumuricacidandtheincidenceofckdandhypertension
AT takahashidaisuke serumuricacidandtheincidenceofckdandhypertension
AT suganonaoki serumuricacidandtheincidenceofckdandhypertension
AT hosoyatatsuo serumuricacidandtheincidenceofckdandhypertension
AT yokootakashi serumuricacidandtheincidenceofckdandhypertension